Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

HQ
951 Gateway Blvd.
South San Francisco, CA, 94080
USA

People

CEO, Board of Directors
Board
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors, Interim CEO
Board of Directors
Show All People

Acquisitions

iZumi Bio, 7/2009

Funding

Tags

iPierian

We are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson’s, and other major unmet medical needs.

Recent Milestones

Videos

Screenshots

iPierian screenshot
Above: iPierian Screenshot -- #1
Uploaded: 9/28/09

Sources

  1. iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming (biocetera.com) [edit]
  2. iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming (biocetera.com) [edit]
  3. iPierian snags $3.7M grant from NIH for cell reprogramming (venturebeat.com) [edit]
  4. SEC (sec.gov) [edit]
  5. iPierian Raises $30M; Funds True North Therapeutics (finsmes.com) [edit]
Edit This Page
Last Edited 1/20/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy